Study Supports Wider Use Of Germline Genetic Testing In Patients With Lung Cancer, Researchers Say

Cancer Therapy Advisor (12/5, Lawrence) reports “results of a new study support wider use of germline genetic testing in patients with lung cancer, according to researchers.” The research found “that about 1 in 7” patients with lung cancer “who underwent genetic testing had a pathogenic germline variant.” That “frequency is higher than previously reported and suggests it may be appropriate to perform germline genetic testing in all” patients with lung cancer, according to researchers. The findings were published in JCO Precision Oncology.